These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8995529)
1. Effects of structural modulation on biological activity of bombesin analogues with (E)-alkene bond. Fujimoto K; Doi R; Hosotani R; Wada M; Lee JU; Koshiba T; Ibuka T; Habashita H; Nakai K; Fujii N; Imamura M Life Sci; 1997; 60(1):29-34. PubMed ID: 8995529 [TBL] [Abstract][Full Text] [Related]
2. Effect of a new bombesin receptor antagonist, (E)-alkene bombesin isostere, on amylase release from rat pancreatic acini. Wada M; Doi R; Hosotani R; Higashide S; Ibuka T; Habashita H; Nakai K; Fujii N; Imamura M Pancreas; 1995 Apr; 10(3):301-5. PubMed ID: 7542772 [TBL] [Abstract][Full Text] [Related]
3. Covalently cyclized agonist and antagonist analogues of bombesin and related peptides. Coy DH; Jiang NY; Kim SH; Moreau JP; Lin JT; Frucht H; Qian JM; Wang LW; Jensen RT J Biol Chem; 1991 Sep; 266(25):16441-7. PubMed ID: 1715866 [TBL] [Abstract][Full Text] [Related]
4. des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists. Wang LH; Coy DH; Taylor JE; Jiang NY; Moreau JP; Huang SC; Frucht H; Haffar BM; Jensen RT J Biol Chem; 1990 Sep; 265(26):15695-703. PubMed ID: 1697594 [TBL] [Abstract][Full Text] [Related]
5. Short chain bombesin pseudopeptides with potent bombesin receptor antagonist activity in rat and guinea pig pancreatic acinar cells. Coy D; Wang LH; Jiang NY; Jensen R Eur J Pharmacol; 1990 Nov; 190(1-2):31-8. PubMed ID: 1963850 [TBL] [Abstract][Full Text] [Related]
6. Effects of potent bombesin antagonist on exocrine pancreatic secretion in rats. Varga G; Reidelberger RD; Liehr RM; Bussjaeger LJ; Coy DH; Solomon TE Peptides; 1991; 12(3):493-7. PubMed ID: 1717952 [TBL] [Abstract][Full Text] [Related]
7. Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells. Wang LH; Coy DH; Taylor JE; Jiang NY; Kim SH; Moreau JP; Huang SC; Mantey SA; Frucht H; Jensen RT Biochemistry; 1990 Jan; 29(3):616-22. PubMed ID: 1692477 [TBL] [Abstract][Full Text] [Related]
8. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity. Coy DH; Taylor JE; Jiang NY; Kim SH; Wang LH; Huang SC; Moreau JP; Gardner JD; Jensen RT J Biol Chem; 1989 Sep; 264(25):14691-7. PubMed ID: 2475489 [TBL] [Abstract][Full Text] [Related]
9. Comparison of prolonged in vivo inhibitory activity of several potent bombesin (BN) antagonists on BN-stimulated amylase secretion in the rat. Alptekin N; Yagci RV; Ertan A; Jiang NY; Rice JC; Sbeiti M; Rossowski WJ; Coy DH Peptides; 1991; 12(4):749-53. PubMed ID: 1724078 [TBL] [Abstract][Full Text] [Related]
10. [D-Ala1, Leu9-psi-CH2NH-Leu10]neuromedin C antagonizes neuromedin C-stimulated amylase release by acini isolated from the rat pancreas. Wisner JR; Xue BG; Coy DH; Renner IG Pancreas; 1990 Jul; 5(4):408-14. PubMed ID: 1696379 [TBL] [Abstract][Full Text] [Related]
11. Actions of novel bombesin receptor antagonists on pancreatic secretion in rats. Jaworek J; Konturek PK; Konturek SJ; Cai RZ; Schally AV Eur J Pharmacol; 1992 Apr; 214(2-3):239-45. PubMed ID: 1381317 [TBL] [Abstract][Full Text] [Related]
12. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes. Mantey S; Frucht H; Coy DH; Jensen RT Mol Pharmacol; 1993 May; 43(5):762-74. PubMed ID: 7684815 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of C-terminal hydroxamide analogues of bombesin. Devin C; Bernad N; Cristau M; Artis-Noel AM; Heitz A; Fehrentz JA; Martinez J J Pept Sci; 1999 Apr; 5(4):176-84. PubMed ID: 10323197 [TBL] [Abstract][Full Text] [Related]
14. Mammalian bombesin receptors are coupled to multiple signal transduction pathways in pancreatic acini. Nishino H; Tsunoda Y; Owyang C Am J Physiol; 1998 Mar; 274(3):G525-34. PubMed ID: 9530154 [TBL] [Abstract][Full Text] [Related]
15. Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity. Coy DH; Heinz-Erian P; Jiang NY; Sasaki Y; Taylor J; Moreau JP; Wolfrey WT; Gardner JD; Jensen RT J Biol Chem; 1988 Apr; 263(11):5056-60. PubMed ID: 2451661 [TBL] [Abstract][Full Text] [Related]
16. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects. Narayan S; Spindel ER; Rubin NH; Singh P Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998 [TBL] [Abstract][Full Text] [Related]
17. Effect of substitutions in position 12 of bombesin on antagonist activity. Saeed ZA; Huang SC; Coy DH; Jiang NY; Heinz-Erian P; Mantey S; Gardner JD; Jensen RT Peptides; 1989; 10(3):597-603. PubMed ID: 2476788 [TBL] [Abstract][Full Text] [Related]
18. Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides. Sekar MC; Uemura N; Coy DH; Hirschowitz BI; Dickinson KE Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):163-9. PubMed ID: 1720612 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of bombesin constrained analogues. Cristau M; Devin C; Oiry C; Chaloin O; Amblard M; Bernad N; Heitz A; Fehrentz JA; Martinez J J Med Chem; 2000 Jun; 43(12):2356-61. PubMed ID: 10882361 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of in vitro and in vivo activities of bombesin pseudopeptide analogs modified on the C-terminal dipeptide fragment. Azay J; Nagain C; Llinares M; Devin C; Fehrentz JA; Bernad N; Roze C; Martinez J Peptides; 1998; 19(1):57-63. PubMed ID: 9437737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]